AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2024
Dec 10, 2024
33298_dirs_2024-12-10_bafcf870-dfa5-4337-a505-cb667a323f98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2024-12-06
Reporting Person: DiTrolio Joseph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-06 | Common Stock | A | 24648 | — | Acquired | 243048 | Direct |
| 2024-12-06 | Common Stock | A | 8000 | — | Acquired | 251048 | Direct |
Footnotes
F1: The grant of restricted shares vests on June 1, 2025
F2: The grant of restricted shares vests immediately
F3: The beneficial holdings have been updated to accurately reflect an exercise of 75,000 shares from an option exercise on June 14, 2024 and previously unaccounted for holdings.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Earnings Release
2025
Nov 17